NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 324 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,050 | -2.6% | 28,460 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $211,458 | +6.7% | 28,460 | -0.5% | 0.02% | 0.0% |
| Q1 2023 | $198,267 | -61.1% | 28,610 | -42.3% | 0.02% | -62.7% |
| Q4 2022 | $510,032 | -43.5% | 49,614 | 0.0% | 0.05% | -46.9% |
| Q3 2022 | $903,000 | -64.6% | 49,614 | 0.0% | 0.10% | -60.7% |
| Q2 2022 | $2,552,000 | -30.2% | 49,614 | 0.0% | 0.24% | -16.4% |
| Q1 2022 | $3,654,000 | -48.5% | 49,614 | 0.0% | 0.29% | -46.6% |
| Q4 2021 | $7,098,000 | -31.0% | 49,614 | 0.0% | 0.55% | -36.7% |
| Q3 2021 | $10,285,000 | -2.4% | 49,614 | 0.0% | 0.86% | +3.2% |
| Q2 2021 | $10,534,000 | – | 49,614 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |